New research suggests that body mass index (BMI) may influence response to topical corticosteroid (tCS) therapy for eosinophilic esophagitis (EoE). The higher the patient's BMI level, the lower the ...

The US Food and Drug Administration approvals of dupilumab (Dupixent, Regeneron/Sanofi) for adults and children with eosinophilic esophagitis (EoE) affirmed the safety and efficacy of the drug, which ...

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in patients with eosinophilic esophagitis at 24 weeks, a randomized phase III ...

Please provide your email address to receive an email when new articles are posted on . Few studies have looked at how corticosteroids impact growth during eosinophilic esophagitis. There were no ...

PHILADELPHIA (WPVI) -- Allergic reactions come in all varieties. One can even trigger a digestive disease which makes it hard to swallow. It's known as EOE - Eosinophilic Esophagitis. For more than 30 ...

The FDA approved budesonide oral suspension (Eohilia) for adults and children ages 11 years and older with eosinophilic esophagitis (EoE), drugmaker Takeda announced. Approval of the 12-week course of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cendakimab sustained improvements in symptoms and ...

Difficulty swallowing is the main symptom of eosinophilic esophagitis (EoE). EoE symptoms often get worse when you're exposed ...

This approach can be long and challenging. It involves multiple steps, frequent endoscopies, and a good deal of time. “We do not have a test we can give to somebody in an easy manner to figure out ...

At first glance, eosinophilic esophagitis (EoE) and asthma may seem like two very different conditions. The former causes inflammation in the esophagus, leading to trouble swallowing, while asthma ...